Product Introduction

The fluorecare® cTnI/CK-MB/MyO Test Kit (Cardiac Triple Panel) developed by Microprofit is a quantitative immunofluorescence assay (FIA) designed for the simultaneous accurate detection of cardiac troponin I (cTnI), creatine kinase isoenzyme (CK-MB), and myoglobin (MyO) in human serum and plasma. As part of the fluorecare® POCT diagnostic platform, this combined test kit enables rapid and reliable quantitative analysis, supporting efficient clinical decision-making in laboratories, hospitals, and point-of-care testing environments.

Detection Principle

The fluorecare® cTnI/CK-MB/MyO test kit utilizes fluorescence immunochromatographic assay technology based on a double-antibody sandwich method. cTnI, CK-MB, and MyO in the sample bind with their respective fluorescent-labeled antibodies to form antigen-antibody complexes, which are captured on dedicated test lines. The fluorescence signal of each marker is positively correlated with its concentration and is detected and analyzed by the fluorecare® immunofluorescence analyzer, enabling accurate and quantitative measurement.

Clinical Applications

• Aid in the diagnosis of acute myocardial infarction (AMI)

• Combined assessment of early, intermediate, and confirmatory cardiac markers

• Risk stratification and triage of patients with chest pain

• Monitoring of myocardial injury and reinfarction

• Clinical laboratory and decentralized POCT testing

Frequently Asked Questions

Q: What is the fluorecare® cTnI/CK-MB/MyO test kit used for?

A: The fluorecare® cTnI/CK-MB/MyO test kit is used for simultaneous quantitative detection of three key cardiac markers to aid in the diagnosis and assessment of myocardial infarction, combining early (MyO), intermediate (CK-MB), and highly specific (cTnI) indicators.

Q: How fast is the fluorecare® cTnI/CK-MB/MyO test?

A: The test provides accurate results within 15 minutes using the fluorecare® immunofluorescence analyzer.

Q: What samples can be used for this test?

A: Serum and plasma samples are suitable for testing with the fluorecare® cTnI/CK-MB/MyO test kit.

Q: Is the fluorecare® cTnI/CK-MB/MyO test suitable for POCT use?

A: Yes, it is specifically designed for point-of-care testing environments.

Compatible Analyzer

The fluorecare® cTnI/CK-MB/MyO test kit is specifically designed to work with the fluorecare® immunofluorescence analyzer (MF-T1000 / MF-T1010), providing fast, accurate, and quantitative results. This integrated POCT solution ensures efficient workflow and reliable performance for laboratories, clinics, and decentralized healthcare settings.

• Simultaneous quantitative detection of cTnI, CK-MB and MyO based on immunofluorescence assay (FIA)

• Rapid results within 15 minutes

• High sensitivity and specificity for each marker

• Seamless integration with fluorecare® POCT platform

• Stable performance with internal calibration

• User-friendly operation with minimal training required

• Suitable for laboratory and point-of-care testing scenarios

REF	MF-148
Product Name	cTnI/CK-MB/MyO Diagnostic Kit
Method	Immunochromatographic assay
Qualification	CE
Testing content	cTnI/CK-MB/MyO
Sample Type	Serum、plasma
Sample Volume（uL）	70μL
Working Range	cTnI：1-50ng/mL CK-MB:0.3-100ng/mL MyO:2.0-400ng/mL
Reaction Time （min）	15
Storage Temperature	2-8℃
Shelf Life	24 months
Applied Instrument	fluorecare® MF-T1000 Dry-type Immunofluorescence Quantitative Analyzer fluorecare® MF-C100 Incubator
Specification	20 tests/kit	25 tests/kit
Size（L*W*H)mm/Kit	145*115*75	205*138*83
Weight(kg)/Kit	0.280	0.337
Kit components	Test Card：20 Cassettes Diluent：20 tubes ID Chip：1 Piece Instruction：1 Copy	Test Card ( including the desiccant）：25 Cassettes Diluent：25 tubes ID Chip：1 Piece Instruction：1 Copy